Patents by Inventor Hironori Okada

Hironori Okada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12255640
    Abstract: A driving circuit that drives a switching element, the driving circuit includes: a controller that includes a first terminal connected to a gate terminal of the switching element and a second terminal connected to a source terminal of the switching element, and outputs a control signal from the first terminal to the gate terminal; a first capacitor and a first resistor connected in parallel; and a second capacitor and a second resistor connected in parallel, in which the first capacitor and the first resistor are connected in series to a first connecting wire for connecting the gate terminal and the first terminal on the gate terminal side of the first connecting wire, and in which the second capacitor and the second resistor are connected in series to the first connecting wire on the first terminal side of the first connecting wire.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: March 18, 2025
    Assignee: OMRON CORPORATION
    Inventors: Noriyuki Nosaka, Hironori Tauchi, Takuro Hashimoto, Wataru Okada, Mamoru Sueki, Satoshi Iwai
  • Publication number: 20210246173
    Abstract: The present invention provides: a mutant of adeno-associated virus (AAV) capsid protein, which contains at least one amino acid substitution in PLA2 domain when compared with the amino acid sequence for wild-type AAV capsid protein; a nucleic acid encoding the mutant; a cell containing the nucleic acid; a method for producing a recombinant AAV particle, comprising a step of culturing the cell to produce the recombinant AAV particle; a recombinant AAV particle containing the mutant; a composition containing the recombinant AAV particle; and a method for transferring a gene into a target cell, comprising a step of bringing the recombinant AAV particle into contact with the target cell.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 12, 2021
    Applicants: NIPPON MEDICAL SCHOOL FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, TAKARA BIO INC.
    Inventors: Takashi OKADA, Hironori OKADA, Hiromi KINOH, Tatsuji ENOKI, Toshikazu NISHIE, Junichi MINENO
  • Patent number: 11028131
    Abstract: The present invention provides: a mutant of adeno-associated virus (AAV) capsid protein, which contains at least one amino acid substitution in PLA2 domain when compared with the amino acid sequence for wild-type AAV capsid protein; a nucleic acid encoding the mutant; a cell containing the nucleic acid; a method for producing a recombinant AAV particle, comprising a step of culturing the cell to produce the recombinant AAV particle; a recombinant AAV particle containing the mutant; a composition containing the recombinant AAV particle; and a method for transferring a gene into a target cell, comprising a step of bringing the recombinant AAV particle into contact with the target cell.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: June 8, 2021
    Assignees: NIPPON MEDICAL SCHOOL FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, TAKARA BIO INC.
    Inventors: Takashi Okada, Hironori Okada, Hiromi Kinoh, Tatsuji Enoki, Toshikazu Nishie, Junichi Mineno
  • Publication number: 20200002384
    Abstract: The present invention provides: a mutant of adeno-associated virus (AAV) capsid protein, which contains at least one amino acid substitution in PLA2 domain when compared with the amino acid sequence for wild-type AAV capsid protein; a nucleic acid encoding the mutant; a cell containing the nucleic acid; a method for producing a recombinant AAV particle, comprising a step of culturing the cell to produce the recombinant AAV particle; a recombinant AAV particle containing the mutant; a composition containing the recombinant AAV particle; and a method for transferring a gene into a target cell, comprising a step of bringing the recombinant AAV particle into contact with the target cell.
    Type: Application
    Filed: January 29, 2018
    Publication date: January 2, 2020
    Applicants: NIPPON MEDICAL SCHOOL FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, TAKARA BIO INC.
    Inventors: Takashi OKADA, Hironori OKADA, Hiromi KINOH, Tatsuji ENOKI, Toshikazu NISHIE, Junichi MINENO
  • Patent number: 7046201
    Abstract: In a diversity antenna apparatus, chip antennas are used as antenna elements, and the chip antennas are disposed in association with a ground pattern with certain gaps from the ground pattern. The chip antennas are disposed so as to surround the ground pattern formed on a substrate, and the ground pattern is shared among the chip antennas. Furthermore, hybrid patterns are included in the substrate, and the hybrid patterns also share the ground pattern with the chip antennas to achieve compact design. Alternatively, a transmitting chip antenna and a ground pattern associated with the transmitting chip antenna together form a vertically polarized antenna, and the transmitting chip antenna and the ground pattern associated with the transmitting chip antenna are separated from receiving chip antennas and a ground pattern associated with the receiving chip antennas.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: May 16, 2006
    Assignee: Taiyo Yuden Co., Ltd.
    Inventor: Hironori Okada